Chicago Partners Investment Group’s Cytosorbents Corp CTSO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.5K | Sell |
12,281
-1,162
| -9% | -$1.19K | ﹤0.01% | 1093 |
|
|
2025
Q1 | $11.9K | Sell |
13,443
-171
| -1% | -$151 | ﹤0.01% | 928 |
|
|
2024
Q4 | $13.2K | Sell |
13,614
-1,371
| -9% | -$1.33K | ﹤0.01% | 845 |
|
|
2024
Q3 | $15.7K | Sell |
14,985
-4,099
| -21% | -$4.3K | ﹤0.01% | 793 |
|
|
2024
Q2 | $22.6K | Sell |
19,084
-11,583
| -38% | -$13.7K | ﹤0.01% | 741 |
|
|
2024
Q1 | $27K | Sell |
30,667
-169
| -0.5% | -$149 | ﹤0.01% | 728 |
|
|
2023
Q4 | $27.4K | Sell |
30,836
-5,522
| -15% | -$4.92K | ﹤0.01% | 693 |
|
|
2023
Q3 | $67.4K | Buy |
36,358
+16,598
| +84% | +$30.8K | ﹤0.01% | 636 |
|
|
2023
Q2 | $66.2K | Buy |
19,760
+9,262
| +88% | +$31K | ﹤0.01% | 667 |
|
|
2023
Q1 | $28.8K | Sell |
10,498
-4,707
| -31% | -$12.9K | ﹤0.01% | 655 |
|
|
2022
Q4 | $59.5K | Buy |
15,205
+2,021
| +15% | +$7.9K | ﹤0.01% | 627 |
|
|
2022
Q3 | $20K | Buy |
13,184
+1,371
| +12% | +$2.08K | ﹤0.01% | 579 |
|
|
2022
Q2 | $27K | Sell |
11,813
-613
| -5% | -$1.4K | ﹤0.01% | 586 |
|
|
2022
Q1 | $28K | Buy |
+12,426
| New | +$28K | ﹤0.01% | 557 |
|